Acumen Pharmaceuticals, Inc. (ABOS) Debt by Year
Acumen Pharmaceuticals, Inc. carried $22.4M in long-term debt against $54.0M in cash and equivalents at the end of fiscal year 2025. This represents a decrease of 23.9% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Acumen Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABOS Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ABOS Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $11.9M-60.2% | $16.9M-42.7% | $22.4M-23.9% | $27.1M-8.8% | $29.9M+1.7% | $29.5M-2.3% | $29.4M-1.6% | $29.7M | $29.4M | $30.2M | $29.9M | N/A |
| Cash & Equivalents | $59.4M+61.5% | $51.8M+71.7% | $54.0M+51.5% | $46.8M+41.1% | $36.8M-45.8% | $30.2M-35.7% | $35.6M-46.7% | $33.2M-65.0% | $68.0M-12.0% | $46.9M-39.8% | $66.9M-48.6% | $94.9M-39.8% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Acumen Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Acumen Pharmaceuticals, Inc.'s long-term debt in fiscal year 2025?
Acumen Pharmaceuticals, Inc. carried $22.4M in long-term debt against $54.0M in cash and equivalents at the end of fiscal year 2025.
How fast is Acumen Pharmaceuticals, Inc.'s long-term debt growing?
Acumen Pharmaceuticals, Inc. (ABOS) long-term debt fell by 23.9% year over year, from $29.4M to $22.4M in fiscal year 2025.
What was Acumen Pharmaceuticals, Inc.'s long-term debt in the most recent quarter?
Acumen Pharmaceuticals, Inc. (ABOS) reported $11.9M in long-term debt in Q2 2026. This represents a decrease of 60.2% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Acumen Pharmaceuticals, Inc. (ABOS) reported on that line in every period on record.